Kathleen Tregoning, M.A
2020
In 2020, Kathleen Tregoning, M.A earned a total compensation of $3.7M as Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $114,378 |
| Option Awards | $3,322,419 |
| Salary | $193,205 |
| Total | $3,730,002 |
MA received $3.3M in option awards, accounting for 89% of the total pay in 2020.
MA also received $100K in bonus, $114.4K in non-equity incentive plan and $193.2K in salary.
Rankings
In 2020, Kathleen Tregoning, M.A's compensation ranked 3,096th out of 13,090 executives tracked by ExecPay. In other words, MA earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,096 out of 13,090 | 76th |
Division Manufacturing | 1,205 out of 5,618 | 79th |
Major group Chemicals And Allied Products | 459 out of 2,251 | 80th |
Industry group Drugs | 397 out of 1,951 | 80th |
Industry Pharmaceutical Preparations | 296 out of 1,456 | 80th |
Source: SEC filing on April 28, 2021.
MA's colleagues
We found four more compensation records of executives who worked with Kathleen Tregoning, M.A at Cerevel Therapeutics Holdings in 2020.